Tag: BCMA CAR-T therapy China

Home / BCMA CAR-T therapy China

Categories

NMPA approves zevorcabtagene autoleucel CAR T Cell therapy for R/R multiple myeloma

Zevor-Cel therapy Chinese regulators have approved zevorcabtagene autoleucel (zevor-cel; CT053), an autologous CAR T-cell therapy, for the treatment of adult patients with multiple myeloma that has r...
bcma-car-t-therapy-china

Scan the code